| pubmed-article:19468225 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19468225 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:19468225 | lifeskim:mentions | umls-concept:C0340288 | lld:lifeskim |
| pubmed-article:19468225 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:19468225 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:19468225 | lifeskim:mentions | umls-concept:C0439133 | lld:lifeskim |
| pubmed-article:19468225 | lifeskim:mentions | umls-concept:C0257190 | lld:lifeskim |
| pubmed-article:19468225 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19468225 | pubmed:dateCreated | 2009-9-4 | lld:pubmed |
| pubmed-article:19468225 | pubmed:abstractText | The antianginal and anti-ischemic efficacy of ivabradine has been demonstrated in large-scale trials. Pooling trial data allowed for subpopulation analyses of ivabradine's antianginal efficacy. | lld:pubmed |
| pubmed-article:19468225 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19468225 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19468225 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19468225 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19468225 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19468225 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19468225 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19468225 | pubmed:issn | 1421-9751 | lld:pubmed |
| pubmed-article:19468225 | pubmed:author | pubmed-author:TardifJean-Cl... | lld:pubmed |
| pubmed-article:19468225 | pubmed:author | pubmed-author:BorerJeffrey... | lld:pubmed |
| pubmed-article:19468225 | pubmed:author | pubmed-author:TenderaMichal... | lld:pubmed |
| pubmed-article:19468225 | pubmed:copyrightInfo | Copyright 2009 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:19468225 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19468225 | pubmed:volume | 114 | lld:pubmed |
| pubmed-article:19468225 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19468225 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19468225 | pubmed:pagination | 116-25 | lld:pubmed |
| pubmed-article:19468225 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:meshHeading | pubmed-meshheading:19468225... | lld:pubmed |
| pubmed-article:19468225 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19468225 | pubmed:articleTitle | Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris. | lld:pubmed |
| pubmed-article:19468225 | pubmed:affiliation | 3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland. michal.tendera@gcm.pl | lld:pubmed |
| pubmed-article:19468225 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19468225 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19468225 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:19468225 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
